These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 3778467)

  • 1. Production of antibodies recognizing a hepatitis B virus (HBV) surface antigen by administration of murabutide associated to a synthetic pre-S HBV peptide conjugated to a toxoid carrier.
    Przewlocki G; Audibert F; Jolivet M; Chedid L; Kent SB; Neurath AR
    Biochem Biophys Res Commun; 1986 Oct; 140(2):557-64. PubMed ID: 3778467
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhancement by murabutide of the immune response to natural and synthetic hepatitis B surface antigens.
    Audibert FM; Przewlocki G; Leclerc CD; Jolivet ME; Gras-Masse HS; Tartar AL; Chedid LA
    Infect Immun; 1984 Jul; 45(1):261-6. PubMed ID: 6735468
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Enhancement of the activity of hepatitis B virus vaccine by association with murabutide].
    Audibert F; Przewlocki G; Lefrancier P; Choay J; Chedid L
    C R Seances Acad Sci III; 1982 Nov; 295(10):611-4. PubMed ID: 6218866
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of biologically active antibodies by a polyvalent synthetic vaccine constructed without carrier.
    Jolivet ME; Audibert FM; Gras-Masse H; Tartar AL; Schlesinger DH; Wirtz R; Chedid LA
    Infect Immun; 1987 Jun; 55(6):1498-502. PubMed ID: 3553005
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of muramyl peptides for the enhancement of synthetic vaccines.
    Chedid L; Audibert F; Jolivet M
    Dev Biol Stand; 1986; 63():133-40. PubMed ID: 3527818
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibody responses elicited by a polyvalent vaccine containing synthetic diphtheric, streptococcal and hepatitis peptides coupled to the same carrier.
    Chedid L; Jolivet M; Audibert F; Przewlocki G; Beachey EH; Gras-Masse H; Tartar A
    Biochem Biophys Res Commun; 1983 Dec; 117(3):908-15. PubMed ID: 6421289
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biologically active antibodies elicited by a synthetic circumsporozoite peptide of Plasmodium knowlesi administered in saline with a muramyl dipeptide derivative.
    Clough ER; Audibert FM; Barnwell JW; Schlesinger DH; Arnon R; Chedid LA
    Infect Immun; 1985 Jun; 48(3):839-42. PubMed ID: 3997250
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Production of anti-sporozoite antibodies in absence of response to carrier by coupling an MDP derivative to a malaria peptide-tetanus toxoid conjugate.
    Clough ER; Jolivet M; Audibert F; Barnwell JW; Schlesinger DH; Chedid L
    Biochem Biophys Res Commun; 1985 Aug; 131(1):70-6. PubMed ID: 4038309
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhancement of immunoglobulin G responses in mice against hepatitis B virus surface antigen, influenza virus hemagglutinin vaccine, and tetanus toxoid by 6-O-acylated muramyl dipeptides.
    Furuya T; Kumazawa Y; Takimoto H; Nagumo T; Watanabe M; Aizawa C; Kiso M; Hasegawa A; Nomoto K
    Infect Immun; 1989 Jun; 57(6):1839-44. PubMed ID: 2722242
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulation of carrier-induced epitopic suppression by Bordetella pertussis components and muramyl peptide.
    Vogel FR; Leclerc C; Schutze MP; Jolivet M; Audibert F; Klein TW; Chedid L
    Cell Immunol; 1987 Jun; 107(1):40-51. PubMed ID: 2438053
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of muramyl dipeptide derivatives as adjuvants on the induction of antibody response to recombinant hepatitis B surface antigen.
    Tamura M; Yoo YC; Yoshimatsu K; Yoshida R; Oka T; Ohkuma K; Arikawa J; Azuma I
    Vaccine; 1995 Jan; 13(1):77-82. PubMed ID: 7762283
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of antibody avidity and titre elicited by peptide as a protein conjugate or as expressed in vaccinia.
    Lew AM; Anders RF; Edwards SJ; Langford CJ
    Immunology; 1988 Oct; 65(2):311-4. PubMed ID: 3056855
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunoadjuvants and analogs of immunomodulatory bacterial structures.
    Lise LD; Audibert F
    Curr Opin Immunol; 1989 Dec; 2(2):269-74. PubMed ID: 2696487
    [No Abstract]   [Full Text] [Related]  

  • 14. Immunity to hepatitis B: analysis of antibody and cellular responses in recipients of a plasma-derived vaccine using synthetic peptides mimicking S and pre-S regions.
    Steward MW; Sisley BM; Stanley C; Brown SE; Howard CR
    Clin Exp Immunol; 1988 Jan; 71(1):19-25. PubMed ID: 3349646
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhancing activity of mycobacterial cell-derived adjuvants on immunogenicity of recombinant human hepatitis B virus vaccine.
    Koike Y; Yoo YC; Mitobe M; Oka T; Okuma K; Tono-oka S; Azuma I
    Vaccine; 1998 Dec; 16(20):1982-9. PubMed ID: 9796054
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel immunostimulator, N-[alpha-O-benzyl-N-(acetylmuramyl)-L-alanyl-D-isoglutaminyl]-N6-trans-(m-nitrocinnamoyl)-L-lysine, and its adjuvancy on the hepatitis B surface antigen.
    Yang HZ; Xu S; Liao XY; Zhang SD; Liang ZL; Liu BH; Bai JY; Jiang C; Ding J; Cheng GF; Liu G
    J Med Chem; 2005 Aug; 48(16):5112-22. PubMed ID: 16078831
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Partial delipidation improves the T-cell antigenicity of hepatitis B virus surface antigen.
    Desombere I; Willems A; Gijbels Y; Leroux-Roels G
    J Virol; 2006 Apr; 80(7):3506-14. PubMed ID: 16537618
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the effects of five adjuvants on the antibody response to influenza virus antigen in guinea pigs.
    Robuccio JA; Griffith JW; Chroscinski EA; Cross PJ; Light TE; Lang CM
    Lab Anim Sci; 1995 Aug; 45(4):420-6. PubMed ID: 7474883
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of adjuvants on the efficacy of a recombinant herpes simplex virus glycoprotein vaccine.
    Sanchez-Pescador L; Burke RL; Ott G; Van Nest G
    J Immunol; 1988 Sep; 141(5):1720-7. PubMed ID: 2842401
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective stimulation of murine cytotoxic T cell and antibody responses by particulate or monomeric hepatitis B virus surface (S) antigen.
    Schirmbeck R; Melber K; Mertens T; Reimann J
    Eur J Immunol; 1994 May; 24(5):1088-96. PubMed ID: 8181520
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.